December 4th (Eastern Time) - $Ensysce Biosciences (ENSC.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from December 6th, 2024.
$Ensysce Biosciences (ENSC.US)$ slipped 6.78% and closed at $0.55 on December 3rd with a turnover of $583.89K. $Ensysce Biosciences (ENSC.US)$ now has a total market capitalization of $10.76 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.